Deng Kan, Li Shuping, Zhang Jian, Ye Xiande, Yao Kai, Li Ying, Xiao Jianru
Department of Orthopedic Oncology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Department of Radiology, Naval Medical Center of People's Liberation Army, Naval Medical University, Shanghai, China.
J Thorac Dis. 2022 Apr;14(4):1130-1138. doi: 10.21037/jtd-22-113.
Non-small cell lung cancer (NSCLC) patients with synchronous solitary metastasis are a heterogeneous population. The analysis and evaluation of NSCLC patients with synchronous solitary bone metastases by cTN stage (thoracic tumor staging) and volume parameters have not yet been studied. The purpose of this study is to estimate the prognostic value of cTN stage and volume parameters obtained by fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in NSCLC patients with synchronous solitary bone metastasis.
A total of 157 NSCLC patients with synchronous solitary bone metastasis were retrospectively analyzed. Patients' cTN stage, metabolic tumor volume (MTV) parameters, and clinical data were collected. Kaplan-Meier survival analysis and a Cox regression model were performed to determine the association between each factor and overall survival (OS). Finally, time-dependent receiver operating characteristic (TDROC) curve analysis was used to assess the predictive capacity of the independent prognostic factors.
Kaplan-Meier survival analysis showed significant differences between subgroups in terms of cTN stage. The median OS of group I was 44 months, and the 5-year survival rate was 39.6%. In the multivariate Cox regression analysis, cTN stage, MTV of the whole body (MTVwb), and MTV of thorax (MTVtho) were significantly associated with patient OS, even after adjusting for other clinical factors. However, MTV of bone (MTVbon) was not found to be an independent prognostic factor. TDROC curve analysis showed that cTN stage, MTVwb, and MTVtho had good predictive capacity for NSCLC patients with synchronous solitary bone metastasis. Compared with cTN stage and MTVtho, MTVwb had obviously better predictive specificity and sensitivity for the 5-year survival rate [5-year area under the curve (AUC) of MTVwb =0.844 cTN stage (P=0.035) MTVtho (P=0.052)]. The best cutoff value of MTVwb was 33.05.
The results of this study confirmed that cTN stage, MTVwb, and MTVtho were independent prognostic factors of NSCLC patients with synchronous solitary bone metastases. These factors can be used for risk stratification of these patients. TDROC curve analysis indicated that cTN stage, MTVtho, and MTVwb had good performance for survival prediction.
伴有同步孤立转移的非小细胞肺癌(NSCLC)患者是一个异质性群体。尚未对通过cTN分期(胸部肿瘤分期)和体积参数对伴有同步孤立骨转移的NSCLC患者进行分析和评估。本研究的目的是评估通过氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)/计算机断层扫描(CT)获得的cTN分期和体积参数在伴有同步孤立骨转移的NSCLC患者中的预后价值。
回顾性分析了157例伴有同步孤立骨转移的NSCLC患者。收集患者的cTN分期、代谢肿瘤体积(MTV)参数和临床数据。进行Kaplan-Meier生存分析和Cox回归模型以确定各因素与总生存期(OS)之间的关联。最后,采用时间依赖性受试者工作特征(TDROC)曲线分析来评估独立预后因素的预测能力。
Kaplan-Meier生存分析显示各亚组在cTN分期方面存在显著差异。I组的中位OS为44个月,5年生存率为39.6%。在多变量Cox回归分析中,即使在调整其他临床因素后,cTN分期、全身MTV(MTVwb)和胸部MTV(MTVtho)与患者OS显著相关。然而,骨MTV(MTVbon)未被发现是独立的预后因素。TDROC曲线分析显示,cTN分期、MTVwb和MTVtho对伴有同步孤立骨转移的NSCLC患者具有良好的预测能力。与cTN分期和MTVtho相比,MTVwb对5年生存率具有明显更好的预测特异性和敏感性[MTVwb的5年曲线下面积(AUC)=0.844>cTN分期(P=0.035)>MTVtho(P=0.052)]。MTVwb的最佳截断值为33.05。
本研究结果证实,cTN分期、MTVwb和MTVtho是伴有同步孤立骨转移的NSCLC患者的独立预后因素。这些因素可用于这些患者的风险分层。TDROC曲线分析表明,cTN分期、MTVtho和MTVwb在生存预测方面表现良好。